Child Growth & Development

Environmental Impacts on miRNAs in Human Milk and Contributions to Early Life Growth and Adiposity

Principal Investigator: Caitlin Howe, PhD
Funding:
National Institute of Environmental Health Sciences
Project Number: 1R01ES036661-01A1  

Complete Project Details

Project Narrative: The proposed research will determine metal impacts on cell composition and miRNA profiles of human milk and consequences for early childhood growth and adiposity. Findings may inform interventions and clinical guidelines that promote human milk quality and reduce early life disparities in obesity.

Highlighted Publications

  • Publication Link: During pregnancy, extracellular vesicle and particle microRNAs (EVP miRNA) in maternal circulation have the capacity to cross the placenta and facilitate maternal-fetal communication. Both dysregulation of circulating EVP miRNA during pregnancy and maternal diet quality have been previously associated with pregnancy complications and adverse birth outcomes. However, little is known about how maternal diet influences circulating EVP miRNA during pregnancy. This study assesses associations between maternal diet quality, as measured by the Alternative Healthy Eating Index (2010; AHEI-2010), and EVP miRNA levels in maternal circulation during pregnancy.

    We identified associations between the consumption of red and processed meat and levels of circulating select EVP miRNA during pregnancy, including placenta-specific miRNA and miRNA with target genes overrepresented in pathways involved in placental development. Additional research is needed to assess whether alterations in maternal circulating EVP miRNA may mediate maternal diet quality’s impacts on pregnancy and birth outcomes.

  • Publication Link: MicroRNAs (miRNA) in extracellular vesicles and particles (EVPs) in maternal circulation during pregnancy and in human milk postpartum are hypothesized to facilitate maternal-offspring communication via epigenetic regulation. However, factors influencing maternal EVP miRNA profiles during these two critical developmental windows remain largely unknown. In a pilot study of 54 mother-child dyads in the New Hampshire Birth Cohort Study, we profiled 798 EVP miRNAs, using the NanoString nCounter platform, in paired maternal second-trimester plasma and mature (6-week) milk samples. In adjusted models, total EVP miRNA counts were lower for plasma samples collected in the afternoon compared with the morning (p = 0.024). Infant age at sample collection was inversely associated with total miRNA counts in human milk EVPs (p = 0.040). Milk EVP miRNA counts were also lower among participants who were multiparous after delivery (p = 0.047), had a pre-pregnancy BMI > 25 kg/m2 (p = 0.037), or delivered their baby via cesarean section (p = 0.021). In post hoc analyses, we also identified 22 specific EVP miRNA that were lower among participants who delivered their baby via cesarean section (Q < 0.05). Target genes of delivery mode-associated miRNAs were over-represented in pathways related to satiety signaling in infants (e.g., CCKR signaling) and mammary gland development and lactation (e.g., FGF signaling, EGF receptor signaling). In conclusion, we identified several key factors that may influence maternal EVP miRNA composition during two critical developmental windows, which should be considered in future studies investigating EVP miRNA roles in maternal and child health.

  • Publication Link: Human milk is a rich source of microRNAs (miRNAs), which can be transported by extracellular vesicles and particles (EVPs) and are hypothesized to contribute to maternal-offspring communication and child development. Environmental contaminant impacts on EVP miRNAs in human milk are largely unknown. In a pilot study of 54 mother-child pairs from the New Hampshire Birth Cohort Study, we examined relationships between five metals (arsenic, lead, manganese, mercury, and selenium) measured in maternal toenail clippings, reflecting exposures during the periconceptional and prenatal periods, and EVP miRNA levels in human milk. 798 miRNAs were profiled using the NanoString nCounter platform; 200 miRNAs were widely detectable and retained for downstream analyses. Metal-miRNA associations were evaluated using covariate-adjusted robust linear regression models. Arsenic exposure during the periconceptional and prenatal periods was associated with lower total miRNA content in human milk EVPs (PBonferroni < 0.05). When evaluating miRNAs individually, 13 miRNAs were inversely associated with arsenic exposure, two in the periconceptional period and 11 in the prenatal period (PBonferroni < 0.05). Other metal-miRNA associations were not statistically significant after multiple testing correction (PBonferroni ≥ 0.05). Many of the arsenic-associated miRNAs are involved in lactation and have anti-inflammatory properties in the intestine and tumor suppressive functions in breast cells. Our findings raise the possibility that periconceptional and prenatal arsenic exposure may reduce levels of multiple miRNAs in human milk EVPs. However, larger confirmatory studies, which can apply environmental mixture approaches, evaluate potential effect modifiers of these relationships, and examine possible downstream consequences for maternal and child health and breastfeeding outcomes, are needed.

Characterizing the functional genomic atlas of human placenta and unveiling the prenatal programming of early-life development

Principal Investigator: Carmen Marsit, PhD
Funding: Emory University, Atlanta, GA
Project Number: 5R01HD108310-03

Complete Project Details

Project Narrative: This project will characterize the functional genome of human term placenta down to the single cellular level in order to reveal how the complex interplay of the in utero environment and genetic variation may impact birthweight and early childhood growth and obesity. Identifying these molecular pathways will be useful in defining prevention or intervention strategies that can be implemented early to alleviate long-term disease burden.

Highlighted Publications

  • Publication Link: Poor placental function is a common cause of intrauterine growth restriction, which in turn is associated with increased risks of adverse health outcomes. Our prior work suggests that birthweight and childhood obesity-associated genetic variants functionally impact placental function and that placental microRNA are associated with birthweight. To address the influence of the placenta beyond birth, we assessed the relationship between placental microRNAs and early childhood growth.

    We found that growth trajectory associated placenta microRNAs target genes involved in signaling pathways central to the formation, maintenance and function of placenta; suggesting that placental cellular dynamics remain critical to infant growth to term and are under the control of microRNAs. Our results contribute to the existing body of research suggesting that the placenta plays a key role in programming health in the offspring. This is the first study to relate molecular patterns in placenta, specifically microRNAs, to early childhood growth trajectory.

The Interplay of Maternal Per- and Polyfluoroalkyl Substances (PFAS) Exposures and Folate Intake in Offspring Neurodevelopment

Principal Investigator: Gyeyoon Yim, ScD, MPH; Mentor: Caitlin Howe, PhD
Funding: The Gerber Foundation
Project Number:  11171

Complete Project Details

Project Narrative: Given the lack of effective treatments to alleviate per- and polyfluoroalkyl substances (PFAS)-related adverse health outcomes, identifying interventions that could reduce the PFAS toxicity is critical. Although growing evidence indicates that the health impact of prenatal PFAS exposure may vary by folate intake levels, little is known about how folate intake during pregnancy may modify the influence of PFAS exposure on neurodevelopment. Using data from a rural US pregnancy cohort, the proposed study will examine how the impact of prenatal PFAS exposure on neurobehavioral development at 3 years of age differs by maternal folate intake levels.

Highlighted Publications

  • Gerber Foundation Award Announcement
    Research Abstract: Previous population-based studies have suggested that maternal exposure to per- and polyfluoroalkyl substances (PFAS) during pregnancy is associated with a higher likelihood of neurodevelopmental disorders among their offspring, including autism spectrum disorder and attention-deficit/hyperactivity disorder. Furthermore, growing evidence indicates that the health impacts of PFAS exposure on adverse birth or immune outcomes, both of which have been associated with neurodevelopmental deficits, may vary by folate levels. Folate is an essential micronutrient, which is actively transported through the placenta for fetal brain development. It is recommended that all women of childbearing age take a supplement containing folic acid daily and the U.S. implemented a folic acid fortification program in 1998 to prevent neural tube defects. 

    However, it is estimated that approximately 10-20% of pregnant individuals experience folate deficiency and 15-20% exceed the recommended intake of folic acid by more than four-fold in the US. While most individuals are exposed to PFAS and consume folate, both of which can cross the placenta and share some biological pathways to affect brain development, our understanding of how folate may influence PFAS neurotoxicity is lacking. To address this knowledge gap, the proposed study aims to examine whether the impacts of prenatal exposure to PFAS vary by folate levels in a US rural pregnancy cohort study. 

Previous
Previous

Rural & Child Health

Next
Next

Molecular Epidemiology